The present invention is directed to a closure, which may include tamper evident capabilities as well as an integrated spout and cap, which may be removably attached in a closing relation to a neck portion and/or access opening of a bottle intended for the containment of a medical solution. One or more embodiments of the closure may also facilitate dispensing of the contained medical solution, or other contained solution.
Ophthalmic preparations and solutions are commonly used to treat a wide variety of conditions, including, without limitation, allergies, bacterial and viral infections, and other eye conditions, such as glaucoma. Indeed, sterile ophthalmic compounds are currently widely used in 503A, 503B, eye institutes, and general hospital pharmacy facilities around the world. Likewise, ophthalmic preparations are widely used in veterinary compounding.
Generally speaking, a typical ophthalmic drug, when compounded, includes several components including, without limitation: an ophthalmic container assembly comprising a bottle, a cap, and a nozzle, which must be assembled and filled while maintaining an aseptic technique for the disposition of a liquid, such as a drug, therein. As may be understood, such aseptic techniques require strict procedures for preparing the drug, such procedures including the preparation thereof within a sterile, Class 5 clean room environment, the preparation therein under a laminal flow hood, and the avoidance of touching component surfaces which may contact the given drug. Because the bottle, cap, and nozzle of the ophthalmic container assembly are, at least initially, separate components, it may be understood the aseptic preparation of an ophthalmic drug can be difficult, time-consuming and labor-intensive. Indeed, one critical step in such a preparation is the assembly of the nozzle on the bottle in a dispensing orientation. As such, the nozzle will typically be in direct contact with the corresponding drug to be dispensed. As a result, the nozzle must be assembled into the ophthalmic container or bottle without personnel or exterior objects touching the nozzle. Such careful assembly must be practiced at least until such ophthalmic container has been filled with the intended solution.
Given these difficulties, there exists a need in the art for a solution to these problems pertaining to the preparation and/or compounding of ophthalmic drugs. If it were possible, one solution might be to develop an improved assembly having a cover structure to facilitate dispensing in the intended manner and a container, preferably in the form of a bottle, for the containment of the intended of ophthalmic or other medical and/or non-medical solution. If any such improved assembly were developed it would preferably also be structurally operative to facilitate maintenance of required sterile conditions by avoiding contact with a nozzle portion of the closure while being secured in fluid communicating relation to the interior of the ophthalmic container or bottle. Moreover, if any such improved assembly were developed it could prove helpful to include cooperative structuring of the closure structure to include a cap which may be secured to the ophthalmic container or bottle in a manner which eliminates or significantly restricts the possibility of contact with the nozzle, while concurrently enabling accurate, reliable and consistent placement of the nozzle in the intended dispensing orientation relative to the ophthalmic container or bottle, such as in an access opening thereof. Moreover, if any such assembly were developed it would preferably also be versatile with an ability to dispense the intended or prescribed solutions, compounds, etc. other than an ophthalmic solution.
The present invention is directed to an assembly for containment and dispensing of a solution specifically including, but not limited to, the containment and dispensing of an ophthalmic or other medical solution, preparation, compound, etc. Moreover, structural and operative features of the various components of the inventive assembly enable the intended attachment or connection to one another in a manner which maintains required or desired aseptic conditions or techniques. Such aseptic conditions or techniques include, but are not limited to the avoidance of contact with portions of the assembly which come into direct engagement with the solution, compound, etc. being dispensed. As is apparent from the detailed description of various embodiments of the present invention provided herein, the subject assembly may be specifically used for the droplet or “drop-by-drop” dispensing of an ophthalmic solution and as such, may be in the form of an eyedropper assembly. However, the versatility of the present invention enables the containment and dispensing of solutions other than ophthalmic or medical solutions.
Therefore, at least one embodiment of the present invention includes a closure for a container intended for retaining a medical or other solution, wherein the container may be in the form of a bottle. As explained in greater detail hereinafter, one or more embodiments of the present invention may utilize a somewhat conventionally structured bottle. In the alternative, a bottle having at least some customized structural and operative features may be utilized.
Further, in at least one embodiment of the invention, the closure includes a cap having a shroud with an open end through which a neck portion of the bottle passes to accomplish a connected, closing relation of the cap with the bottle's neck or neck portion. In cooperation therewith, a spout or nozzle is disposed in closing relation or engagement with an access opening of the bottle. The shroud of the cap is disposed, dimensioned and structured to surround and substantially enclose an at least partially hollow interior of the cap. Also, the closure may include an indicator member structured to provide evidence of tampering, such as by providing a clear visual indication of an initial removal of the cap from the aforementioned closing relation to the neck and/or access opening of the bottle.
In at least one embodiment, the indicator member includes a base and an indicator segment, wherein the indicator segment is removably and/or detachably connected to the base. As initially produced, the indicator member may be formed by injection molding and assembled by fixedly disposing, connecting or attaching the indicator member to an interior of the cap, and in such a secured position, the indicator member will preferably be disposed inwardly of the open end of the shroud. Also, in such a secured interior position, the indicator member will preferably not be visually observable from an exterior of the cap, when the cap is disposed in the aforementioned closed relation to the neck of the bottle and access opening. For purposes of clarity, it is emphasized that the preferably non-visually observable position of the indicator member while connected on the interior of the cap, and concurrent to the cap being secured or disposed in closing relation to the bottle is meant to describe that there is significant difficulty in an ability to view the indicator member. This is due at least in part to the cooperative structuring of the closure, including the cap and the dimension and configuration of the bottle, which would render viewing of the indicator member, while intact within the interior of the cap difficult, but not necessarily impossible.
As noted above, additional structural and operative features of the indicator member include a base and an indicator segment. The indicator segment is removably attached to the base of the indicator member preferably by a frangible, breakable connection. The structural features of such a frangible connection are such as to cause the breakage thereof and the detachment of the indicator segment from the base upon a removal of the cap from its connected, closed relation to the neck and access opening of the bottle. As described in greater detail hereinafter, the cooperative structuring of the cap and the exterior portion of the bottle neck may be such as to at least partially define a removable, threaded attachment of the cap to the neck of the bottle. Accordingly, an unscrewing or unthreading of the cap relative to the bottle neck will result in both rotational forces (torque) and axial load or force being exerted on the indicator member. In that the base is secured to the interior surface of the cap and/or shroud, it is movable therewith upon removal of the cap from the bottle.
Such removal force will be sufficient to break the frangible connection causing a detachment of the indicator segment from the base. Once so detached, the indicator segment will fall, pass or drop through the open end of the shroud onto a lower portion of the neck. The dimension and configuration of the shroud are such as to leave an uncovered space or opening on the neck below the open end of the shroud. Therefore, upon disconnection of the indicator segment from the base and the passage of the detached indicator segment through the open end of the shroud, it will be disposed within the opening or space on the bottle neck in a position which is clearly, visually observable. Therefore, the indicator segment will normally be disposed exteriorly of the shroud, even when the cap is reconnected in the closing relation to the bottle neck and access opening of the bottle.
Further, the visually observable location of the indicator segment, once detached from the base, will be sufficiently removed or spaced from the open end of the shroud to facilitate its visual observation. Accordingly, the tamper evident capabilities of the indicator member will include the clear visual observation of the indicator segment, once detached from the base of the indicator member, as the cap is removed or unscrewed from the neck of the bottle. Moreover, if and when the cap is replaced in closing relation to the neck and access opening of the bottle, the detached indicator segment will still remain exteriorly of the shroud and thereby, be clearly observable. Such observance will provide a clear indication that the cap had been previously and/or originally removed, rendering the contents of the bottle accessible and no longer sterile. In order to further emphasize the location of the detached indicator segment when disposed exteriorly of the shroud, it may include a bright or easily noticeable color, preferably distinguishable from the color of the cap or bottle.
Yet additional structural features of at least one embodiment of the present invention includes the indicator member, including both the base and the indicator segment, having a substantially annular or ring-like configuration. As such, the indicator member, when intact and fixedly connected to the interior surface of the cap, will be disposed inwardly from the open end of the shroud. When the cap is connected in the closing relation to the neck and opening of the bottle, the indicator member, including the base and the indicator segment, will be disposed in surrounding relation to the neck of the bottle.
In order to facilitate the aforementioned detachment of the indicator segment from the base, the indicator member is cooperatively structured with a portion of the neck of the bottle, such as with an exterior protrusion formed thereon, to enable a snap-fit connection therebetween. Such a snap fit connection is facilitated by a portion of the indicator member such as, but not limited to, the frangible structure or connection being at least minimally flexible. In cooperation therewith, the indicator segment or other appropriate portion of the indicator member will be cooperatively disposed and structured with the aforementioned exterior protrusion on the neck of the bottle. Therefore, when the cap is screwed onto or otherwise secured in closing relation to the neck and the access opening of the bottle, the indicator segment will movably engage and slide over an appropriately and cooperatively configured part of the aforementioned exterior protrusion extending outwardly from the outer surface of the bottle neck.
Therefore, such a snap-fit connection will further facilitate an initially secure engagement of the indicator segment with the neck of the bottle, when it is still attached to the base and while the base of the indicator member is fixedly secured to the interior surface of the shroud. However, upon detachment of the indicator segment from the base, the aforementioned snap-fit connection of the indicator member to the neck of the bottle will be broken, allowing the indicator segment to pass to a lower level of the neck. The indicator member will then be disposed exteriorly of the overlying shroud, including when the cap is replaced on the bottle after an initial or subsequent access to the contents of the bottle.
At least one embodiment of the closure of the present invention comprises an assembly which includes an integrated construction of the cap and spout. Such an integrated construction is operative to maintain the aseptic conditions during assembly of the cap, spout and bottle prior to the initial filling of the bottle with the selected ophthalmic or other solution. In more specific terms, and as recognized in the prior art, proper sterile conditions can be maintained by eliminating or significantly restricting the possibility of touching any structural part of the closure which comes into direct contact with the contained solution within the bottle. This specifically includes but is not necessarily limited to the spout.
Moreover, the aforementioned integrated construction embodied in the closure comprises the spout disposed in an initially fixed, but subsequently removable connection with the cap. As such, the spout is movable with the cap, as the cap is disposed in the aforementioned closing relation to the bottle neck. More specifically, when assembled the spout will be disposed at least partially into the access opening of the bottle and in sealing engagement therewith. However, due to the spout being integrated into a fixed, but removable connection on the interior of the cap, the spout will move with the cap, as the cap and spout are being connected, in the manner described, to the neck and access opening of the bottle. As should be apparent, the integrated location of the spout on the interior of the cap will prevent or significantly restrict it from being touched, while connecting the cap and spout to the bottle, such as subsequent to filling. In contrast, while the cap will be freely exposed in overlying in closing relation to the spout, it can be safely handled or manipulated to accomplish the connection of the cap and spout to the neck and access opening of the bottle. Aseptic conditions will be maintained because the cap will not come into direct contact with the ophthalmic solution or other contents of the bottle.
Further, the aforementioned fixed, removable integrated connection of the spout on the interior of the cap may be defined by a press fit or frictional engagement of the exterior of the outer segment of the spout with the interior surface of the cap. Such a frictional engagement and/or press fit attachment can be more specifically defined by one or more outwardly extending surface portions formed on the exterior surface of the outer segment of the spout. Therefore, the outer segment, including the one or more outer surface portions are disposed and dimensioned to accomplish the press fit, frictional engagement with correspondingly disposed interior surfaces of the cap. Such press fit or frictional engagement will be sufficient to fixedly but removably maintain attachment of the spout with the cap such as, but not limited to, during concurrent movement of the cap and spout into the closing engagement and/or relation with the neck and access opening of the bottle. In contrast, the un-threading of the cap from the neck of the bottle will result in a removal of the spout from the cap, as the cap disengages the neck of the bottle. This maintained placement and positioning spout in closing relation to the access opening is due at least in part to the fluid tight seal between the exterior surface of the inner segment of the spout and the interior surface of the bottle adjacent and/or contiguous to the access opening.
In the alternative, the integrated connection of the spout within the interior of the cap may be accomplished by a bayonet connector including two connecting segments. When utilized, different ones of the two connecting segments of the bayonet connector is attached to a different one of the spout, such as on the outer segment of the spout, and the cap, such as adjacent the interior surface thereof. The fixed connection and removable detachment of the two bayonet connecting segments facilitates a fixed but removable bayonet connection of the spout and the interior of the cap.
Yet additional features of the spout include the inner segment thereof being disposed in inwardly spaced relation from the exterior surface of the shroud. As indicated herein, the interior surface of the shroud may also include a connector structure, such as threads, which facilitate a threaded or rotational connection of the cap to the neck of the bottle. The inward spacing of the inner segment of the spout from the interior surface and connector structure of the shroud will allow the positioning of the outer end of the bottle neck to pass between the inner segment and the interior surface of the shroud, as the spout and the cap are secured to the bottle neck. As indicated, such attachment of the cap to the bottle neck will include the inner segment of the spout being disposed within and/or through the access opening in sealing engagement with the interior surface of the bottle contiguous to the access opening.
Structural details of the spout comprise the inclusion of a flow channel formed in the spout and extending therethrough. When the cap is connected to the neck of the bottle in closing relation thereto, the flow channel is disposed in fluid communication with an interior of the bottle, via the bottle access opening, concurrent to the spout being connected in closing sealing relation to the access opening of the bottle. When so connected, the spout is at least partially disposed within the bottle access opening, concurrent to the spout connected to the bottle neck. As with known dispensing of ophthalmic solutions, such as a conventional eyedropper, the dispensing of the ophthalmic solution is in droplets or by a “drop-by-drop” manner. Therefore, the dimension, configuration and overall structure of the flow channel, as well as the spout itself, may be such as to define a droplet dispensing of the fluid within the interior of the bottle.
In at least one embodiment, the present invention further comprises the closure having an integrated construction between the cap and a spout, but also being absent the hidden or shrouded indicator member, which is structurally operative to provide an indication of tampering. Moreover, this additional embodiment is directed to a closure comprising a cap including a shroud, wherein the shroud includes an open end. Further, the spout is connected in fixed, removable engagement with the cap to define the integrated construction therebetween.
As set forth above, such an integrated fixed but removable attachment ensures that the spout is movable with the cap into a closing relation to a bottle access opening. Similarly, the spout includes an inner segment disposed within the access opening of the spout in sealing engagement with the adjacent or contiguous interior surfaces of the bottle. As indicated, the spout also includes an outer segment disposed in the aforementioned fixed, but removable connection with interior surface portions of the cap, to define the aforementioned integrated connection therebetween. Also similarly, the inner segment is disposed in inwardly spaced relation to an inner surface of the shroud concurrent to the fixed, removable connection of the outer segment with the interior surfaces of the cap.
These and other objects, features and advantages of the present invention will become clearer when the drawings as well as the detailed description are taken into consideration.
For a fuller understanding of the nature of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
The invention now will be described more fully hereinafter with reference to the accompanying drawings in which illustrative embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
The present invention is directed to an assembly generally indicated as 100 for the containment and dispensing of a solution specifically including, but not limited to, the containment and dispensing of an ophthalmic or other medical solution, preparation, compound, etc. Moreover, structural and operative features of the various components of the assembly 100 enable the intended attachment or connection to one another in a manner which maintains either required or desired aseptic conditions or techniques. Such aseptic conditions or techniques include, but are not limited to, the avoidance of contact with portions of the assembly which come into direct engagement with the solution, compound, etc. being dispensed. The subject assembly 100 may be specifically used for the droplet or “drop-by-drop” dispensing of an ophthalmic solution and as such, be in the form of an eyedropper assembly. However, it is again pointed out that the versatility of the present invention enables the containment and dispensing of solutions other than ophthalmic or medical solutions.
Therefore, and with initial reference to
Further, at least one embodiment of the closure 10 includes a cap 14 including a shroud 16 as perhaps best shown in
As represented throughout
For purposes of clarity, it is emphasized that the non-visually observable interior fixed or secured disposition of the indicator member 26, while connected on the interior of the cap 14, and concurrent to the cap being secured or disposed in closing relation to the bottle 12, is meant to describe a significant difficulty of viewing the indicator member 26. This is due at least in part to the cooperative structuring of the closure 10, including the cap 14 and the dimension and configuration of the bottle 12 which would render viewing of the indicator member 26, while intact within the interior of the cap 14, difficult, but not necessarily impossible.
Additional structural and operative features of the indicator member 26 include a base 32 and an indicator segment 34. The indicator segment 34 is removably attached to the base 32 of the indicator member 26 preferably by a frangible, breakable connection 31. The structural features of such a frangible connection 31 are such as to cause the breakage thereof and the detachment of the indicator segment 34 from the base 32 upon a removal of the cap 14 from its connected, closed relation to the neck 20 and access opening 24 of the bottle 12. Further structural features of the frangible connection 31 comprise it including or being formed of at least one or a plurality of frangible segments 31′.
As represented in at least
Again with reference to
Further, the visually observable location of the indicator segment 34, once detached from the base 32 (e.g., as shown in
Yet additional structural features of at least one embodiment of the present invention include the indicator member 26, including both the base 32 and the indicator segment 34, having a substantially annular or ring-like configuration. As such, the indicator member 26 when intact and fixedly connected to the interior surface of the cap 14 and/or shroud 16, will be disposed inwardly from the open end 18 of the shroud 16. When the cap 14 is connected in the closing relation to the neck 20 and access opening 24 of the bottle 12, the indicator member 26, including the base 32 and the indicator segment 34, will be disposed in surrounding relation to the neck 20 of the bottle 12 as represented in at least
In order to facilitate the aforementioned detachment of the indicator segment 34 from the base 32, the indicator member 26 is cooperatively structured with a portion of the neck 20 of the bottle 12, such as with an exterior protrusion 38 formed thereon, to enable a snap-fit connection therebetween, as represented in
Therefore, such a snap-fit connection will further facilitate an initially secure engagement of the indicator segment 34 with the neck 20 of the bottle 12 when it is still attached to the base 32, and while the base 32 of the indicator member 26 is fixedly secured to the interior surface of the shroud 16, as set forth above. However, upon detachment of the indicator segment 34 from the base 32, the aforementioned snap-fit connection of the indicator member 26 to the neck 20 of the bottle 12 will be broken, allowing the indicator segment 34 to pass to a lower level 20′ of the neck 20. The indicator segment 34 will then be disposed exteriorly of the overlying shroud 16, including when the cap 14 is replaced on the bottle 12 after an initial or subsequent access to the contents of the bottle 12.
Moreover, in at least one embodiment of the present invention, the closure 10 comprises an assembly 100, which includes an integrated construction of the cap 14 and spout 22. Such an integrated construction is operative to maintain the aseptic conditions during assembly of the cap 14, spout 22 and bottle 12 prior to the initial filling of the bottle 12 with the selected ophthalmic or other solution. In more specific terms and as recognized in the prior art, proper sterile conditions can be maintained by eliminating or significantly restricting the possibility of touching any structural part of the closure 10 which comes into direct contact with the contained solution within the bottle 12. This specifically includes, but is not necessarily limited to, the spout 22.
With reference to at least
Moreover, the aforementioned integrated construction embodied in the closure comprises the spout 22 disposed in an initially fixed, but subsequently removable connection with the cap 14. As such, the spout 22 is movable with the cap 14 as it is disposed in the aforementioned closing relation to the bottle neck 20. More specifically, and when assembled, the inner segment 23 of the spout 22 will be disposed at least partially into the access opening 24 of the bottle 12 and in sealing engagement therewith. However, due to the spout 22 being integrated into a fixed, but removable connection on the interior of the cap 14, the spout 22 will move with the cap 14, when the cap 14 and the spout 22 are being collectively connected, in the manner described, to the neck 20 and access opening 24 of the bottle 12. As should be apparent, the integrated location of the spout 22 on the interior of the cap 14 will prevent or significantly restrict it from being touched while connecting the cap 14 and spout 22 to the bottle 12, such as subsequent to filling. In contrast, while the cap 14 will be freely exposed in overlying at least partially enclosing relation to the spout 22, it can be safely handled or manipulated to accomplish the connection of the cap 14 and spout 22 to the neck 20 and access opening 24 of the bottle 12. Aseptic conditions will be maintained because the cap 14 will not come into direct contact with the ophthalmic solution or other contents of the bottle.
Further, the aforementioned fixed, removable integrated connection of the spout 22 on the interior of the cap 14 may be defined by a press fit or frictional engagement of the exterior of the outer segment 25 of the spout 22 with the interior surface of the cap 14, as represented in
In the alternative, the integrated connection of the spout 22 within the interior of the cap 14 may be accomplished by a bayonet connector 40 including two connecting segments 42 and 44, as represented schematically in
Yet additional features of the spout 22 include the inner segment 23 being disposed in inwardly spaced relation from the exterior surface of the shroud 16, as perhaps best represented in
Additional structural details of the spout 22 include a flow channel 22′ formed in and extending therethrough as clearly represented in
To further clarify the present invention, a sequential review of
More specifically,
As described in detail herein,
As represented in the embodiment of
In the alternative, and as also set forth above the fixed, removable integrated connection of the spout 22 within the interior of the cap 14 and/or shroud 16 may be accomplished utilizing the bayonet connector 40 as represented in
In another embodiment of the present invention, the bottle 12 is adapted for containment of the solution to be dispensed. As such, the bottle may comprise a customized construction and be formed as one piece such as by injection molding. This customized bottle 12 may be specifically structured to accomplish interaction with the aforementioned hidden or shrouded indicator member of the embodiment of
Yet another embodiment of the present invention is represented in
Since many modifications, variations and changes in detail can be made to the described preferred embodiment of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
The present application is based on, and a claim of priority is made under 35 U.S.C. Section 119 (e) to a provisional patent application that is in the U.S. Patent and Trademark Office, namely, that having Ser. No. 63/252,016, and a filing date of Oct. 4, 2021, as well as to another provisional patent application in the U.S. Patent and Trademark Office, namely, that having Ser. No. 63/339,925, and a filing date of May 9, 2022, with the contents of both being incorporated herein by reference, in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
722943 | Chappell | Mar 1903 | A |
732662 | Smith | Jun 1903 | A |
1678991 | Marschalek | Jul 1928 | A |
1970631 | Sherman | Aug 1934 | A |
2186888 | Tullar et al. | Jan 1940 | A |
2277936 | Rosenblatt | Mar 1942 | A |
2459304 | Blank | Jan 1949 | A |
2477598 | Hain | Aug 1949 | A |
2734665 | Flamm | Feb 1956 | A |
2739590 | Yochem | Mar 1956 | A |
2811283 | Bowen | Oct 1957 | A |
2823674 | Yochem | Feb 1958 | A |
2834346 | Adams | May 1958 | A |
2875761 | Helmer et al. | Mar 1959 | A |
2888015 | Hunt | May 1959 | A |
2952255 | Hein, Jr. | Sep 1960 | A |
3122280 | Goda | Feb 1964 | A |
3180532 | Michel | Apr 1965 | A |
3245567 | Knight | Apr 1966 | A |
3323798 | Miller | Jun 1967 | A |
3364890 | Andersen | Jan 1968 | A |
3368673 | Johnson | Feb 1968 | A |
3489268 | Meierhoefer | Jan 1970 | A |
3568673 | Cowley | Mar 1971 | A |
3574306 | Alden | Apr 1971 | A |
3598120 | Mass | Aug 1971 | A |
3610241 | LeMarie | Oct 1971 | A |
3674181 | Marks et al. | Jul 1972 | A |
3700215 | Hardman et al. | Oct 1972 | A |
3706307 | Hasson | Dec 1972 | A |
3712749 | Roberts | Jan 1973 | A |
3726445 | Ostrowsky et al. | Apr 1973 | A |
3747751 | Miller et al. | Jul 1973 | A |
3850329 | Robinson | Nov 1974 | A |
3872867 | Killinger | Mar 1975 | A |
3904033 | Haerr | Sep 1975 | A |
3905375 | Toyama | Sep 1975 | A |
3937211 | Merten | Feb 1976 | A |
3987930 | Fuson | Oct 1976 | A |
4005739 | Winchell | Feb 1977 | A |
4043334 | Brown et al. | Aug 1977 | A |
4046145 | Choksi et al. | Sep 1977 | A |
4068696 | Winchell | Jan 1978 | A |
4085845 | Perfect | Apr 1978 | A |
4106621 | Sorenson | Aug 1978 | A |
4216585 | Hatter | Aug 1980 | A |
4216872 | Bean | Aug 1980 | A |
4244366 | Raines | Jan 1981 | A |
4252122 | Halvorsen | Feb 1981 | A |
4271972 | Thor | Jun 1981 | A |
4286591 | Raines | Sep 1981 | A |
4286640 | Knox et al. | Sep 1981 | A |
4313539 | Raines | Feb 1982 | A |
4369781 | Gilson et al. | Jan 1983 | A |
4420085 | Wilson et al. | Dec 1983 | A |
4430077 | Mittleman et al. | Feb 1984 | A |
4433790 | Gibson | Feb 1984 | A |
4457445 | Hanks et al. | Jul 1984 | A |
4482071 | Ishiwatari | Nov 1984 | A |
D277783 | Beck | Feb 1985 | S |
4520942 | Dwinell | Jun 1985 | A |
4521237 | Logothetis | Jun 1985 | A |
4530697 | Kuhlemann et al. | Jul 1985 | A |
4571242 | Klien et al. | Feb 1986 | A |
4589171 | McGill | May 1986 | A |
4664259 | Landis | May 1987 | A |
4667837 | Vitello et al. | May 1987 | A |
4676530 | Nordgren et al. | Jun 1987 | A |
4693707 | Dye | Sep 1987 | A |
4726483 | Drozd | Feb 1988 | A |
4735617 | Nelson et al. | Apr 1988 | A |
4742910 | Staebler | May 1988 | A |
4743229 | Chu | May 1988 | A |
4743231 | Kay et al. | May 1988 | A |
4753345 | Goodsir et al. | Jun 1988 | A |
4760847 | Vaillancourt | Aug 1988 | A |
4813564 | Cooper et al. | Mar 1989 | A |
4832695 | Rosenberg et al. | May 1989 | A |
4834706 | Beck et al. | May 1989 | A |
4842592 | Caggiani et al. | Jun 1989 | A |
4844906 | Hermelin et al. | Jul 1989 | A |
4863451 | Marder | Sep 1989 | A |
4906231 | Young | Mar 1990 | A |
4919285 | Roof et al. | Apr 1990 | A |
4936445 | Grabenkort | Jun 1990 | A |
5007535 | Meseke et al. | Apr 1991 | A |
5009323 | Montgomery et al. | Apr 1991 | A |
5024323 | Bolton | Jun 1991 | A |
5049129 | Zdeb et al. | Sep 1991 | A |
5057093 | Clegg et al. | Oct 1991 | A |
D323392 | Bryne | Jan 1992 | S |
5078696 | Nedbaluk | Jan 1992 | A |
5085332 | Gettig et al. | Feb 1992 | A |
5090564 | Chimienti | Feb 1992 | A |
5133454 | Hammer | Jul 1992 | A |
5135496 | Vetter et al. | Aug 1992 | A |
5163922 | McElveen, Jr. et al. | Nov 1992 | A |
5165560 | Ennis, III et al. | Nov 1992 | A |
5230429 | Etheredge, III | Jul 1993 | A |
5267983 | Oilschlager et al. | Dec 1993 | A |
5292308 | Ryan | Mar 1994 | A |
5293993 | Yates, Jr. et al. | Mar 1994 | A |
5295599 | Smith | Mar 1994 | A |
5312367 | Nathan | May 1994 | A |
5312368 | Haynes | May 1994 | A |
5316163 | von Schuckmann | May 1994 | A |
5328466 | Denmark | Jul 1994 | A |
5328474 | Raines | Jul 1994 | A |
5332113 | Kusler, III et al. | Jul 1994 | A |
5356380 | Hoekwater et al. | Oct 1994 | A |
5370226 | Gollobin et al. | Dec 1994 | A |
5380295 | Vacca | Jan 1995 | A |
5402887 | Shillington | Apr 1995 | A |
5405339 | Kohnen et al. | Apr 1995 | A |
5456668 | Ogle, II | Oct 1995 | A |
5458580 | Hajishoreh | Oct 1995 | A |
5468224 | Souryal | Nov 1995 | A |
5474178 | DiViesti et al. | Dec 1995 | A |
5505705 | Galpin et al. | Apr 1996 | A |
5531695 | Swisher | Jul 1996 | A |
5540324 | Knapp | Jul 1996 | A |
5540666 | Barta et al. | Jul 1996 | A |
5549571 | Sak | Aug 1996 | A |
5558648 | Shields | Sep 1996 | A |
5584817 | van den Haak | Dec 1996 | A |
5588239 | Anderson | Dec 1996 | A |
5611445 | Kano et al. | Mar 1997 | A |
5617954 | Kato et al. | Apr 1997 | A |
5624402 | Imbert | Apr 1997 | A |
5662233 | Reid | Sep 1997 | A |
5674209 | Yarger | Oct 1997 | A |
5695470 | Roussigne et al. | Dec 1997 | A |
5699913 | Richardson | Dec 1997 | A |
5700247 | Grimard et al. | Dec 1997 | A |
5702374 | Johnson | Dec 1997 | A |
5713485 | Liff et al. | Feb 1998 | A |
5776124 | Wald | Jul 1998 | A |
5785691 | Vetter et al. | Jul 1998 | A |
5797885 | Rubin | Aug 1998 | A |
5807343 | Tucker et al. | Sep 1998 | A |
5829589 | Nguyen et al. | Nov 1998 | A |
D402766 | Smith et al. | Dec 1998 | S |
5842567 | Rowe et al. | Dec 1998 | A |
5876381 | Pond et al. | Mar 1999 | A |
5883806 | Meador et al. | Mar 1999 | A |
5884457 | Ortiz et al. | Mar 1999 | A |
5901866 | Storar | May 1999 | A |
5902269 | Jentzen | May 1999 | A |
5926922 | Stottle | Jul 1999 | A |
5951522 | Rosato et al. | Sep 1999 | A |
5951525 | Thorne et al. | Sep 1999 | A |
5954203 | Marconi | Sep 1999 | A |
5954657 | Rados | Sep 1999 | A |
5957166 | Safabash | Sep 1999 | A |
5957314 | Nishida et al. | Sep 1999 | A |
5963136 | O'Brien | Oct 1999 | A |
5989227 | Vetter et al. | Nov 1999 | A |
5993437 | Raoz | Nov 1999 | A |
6000548 | Tsals | Dec 1999 | A |
D419671 | Jansen | Jan 2000 | S |
6021824 | Larsen et al. | Feb 2000 | A |
6027482 | Imbert | Feb 2000 | A |
6068614 | Kimber et al. | May 2000 | A |
D430293 | Jansen | Aug 2000 | S |
6112951 | Mueller | Sep 2000 | A |
D431864 | Jansen | Oct 2000 | S |
6126640 | Tucker et al. | Oct 2000 | A |
6190364 | Imbert | Feb 2001 | B1 |
6193688 | Balestracci et al. | Feb 2001 | B1 |
6196593 | Petrick et al. | Mar 2001 | B1 |
6196998 | Jansen et al. | Mar 2001 | B1 |
6216885 | Guillaume | Apr 2001 | B1 |
6279746 | Hussaini et al. | Apr 2001 | B1 |
6235376 | Miyazaki et al. | May 2001 | B1 |
6280418 | Reinhard et al. | Aug 2001 | B1 |
6287671 | Bright et al. | Sep 2001 | B1 |
6322543 | Singh et al. | Nov 2001 | B1 |
6338200 | Baxa et al. | Jan 2002 | B1 |
6358241 | Shapeton et al. | Mar 2002 | B1 |
6375640 | Teraoka | Apr 2002 | B1 |
6394983 | Mayoral et al. | May 2002 | B1 |
6439276 | Wood et al. | Aug 2002 | B1 |
6485460 | Eakins et al. | Nov 2002 | B2 |
6488666 | Geist | Dec 2002 | B1 |
6491665 | Vetter et al. | Dec 2002 | B1 |
6500155 | Sasso | Dec 2002 | B2 |
6520935 | Jansen et al. | Feb 2003 | B1 |
6540697 | Chen | Apr 2003 | B2 |
6565529 | Kimber et al. | May 2003 | B1 |
6581792 | Limanjaya | Jun 2003 | B1 |
6585691 | Vitello | Jul 2003 | B1 |
6592251 | Edwards et al. | Jul 2003 | B2 |
6666852 | Niedospial, Jr. | Dec 2003 | B2 |
6682798 | Kiraly | Jan 2004 | B1 |
6726652 | Eakins et al. | Apr 2004 | B2 |
6726672 | Hanly et al. | Apr 2004 | B1 |
6764469 | Broselow | Jul 2004 | B2 |
6796586 | Werth | Sep 2004 | B2 |
6821268 | Balestracci | Nov 2004 | B2 |
D501549 | McAllister et al. | Feb 2005 | S |
6921383 | Vitello | Jul 2005 | B2 |
6935560 | Andreasson et al. | Aug 2005 | B2 |
6942643 | Eakins et al. | Sep 2005 | B2 |
6991126 | Jackel | Jan 2006 | B2 |
7036661 | Anthony et al. | May 2006 | B2 |
7055273 | Roshkoff | Jun 2006 | B2 |
7100771 | Massengale et al. | Sep 2006 | B2 |
7125397 | Woehr et al. | Oct 2006 | B2 |
7141286 | Kessler et al. | Nov 2006 | B1 |
7175081 | Andreasson et al. | Feb 2007 | B2 |
7182256 | Andreasson et al. | Feb 2007 | B2 |
7232066 | Anderasson et al. | Jun 2007 | B2 |
7240926 | Dalle et al. | Jul 2007 | B2 |
7299981 | Hickle et al. | Nov 2007 | B2 |
7374555 | Heinz et al. | May 2008 | B2 |
7404500 | Marteau et al. | Jul 2008 | B2 |
7410803 | Nollert et al. | Aug 2008 | B2 |
7425208 | Vitello | Sep 2008 | B1 |
7437972 | Yeager | Oct 2008 | B2 |
D581046 | Sudo | Nov 2008 | S |
D581047 | Koshidaka | Nov 2008 | S |
D581049 | Sudo | Nov 2008 | S |
7482166 | Nollert et al. | Jan 2009 | B2 |
D589612 | Sudo | Mar 2009 | S |
7497330 | Anthony et al. | Mar 2009 | B2 |
7503453 | Cronin et al. | Mar 2009 | B2 |
7588563 | Guala | Sep 2009 | B2 |
7594681 | DeCarlo | Sep 2009 | B2 |
7608057 | Woehr et al. | Oct 2009 | B2 |
7611487 | Woehr et al. | Nov 2009 | B2 |
7632244 | Buehler et al. | Dec 2009 | B2 |
D608900 | Giraud et al. | Jan 2010 | S |
7641636 | Moesli et al. | Jan 2010 | B2 |
D612939 | Boone, III et al. | Mar 2010 | S |
7681606 | Khan et al. | Mar 2010 | B2 |
7698180 | Fago et al. | Apr 2010 | B2 |
7735664 | Peters et al. | Jun 2010 | B1 |
7748892 | McCoy | Jul 2010 | B2 |
7762988 | Vitello | Jul 2010 | B1 |
7766919 | Delmotte | Aug 2010 | B2 |
7802313 | Czajka | Sep 2010 | B2 |
7886908 | Farrar et al. | Feb 2011 | B2 |
7918830 | Langan et al. | Apr 2011 | B2 |
7922213 | Werth | Apr 2011 | B2 |
7988004 | Marret | Aug 2011 | B1 |
8034041 | Domkowski et al. | Oct 2011 | B2 |
8079518 | Turner et al. | Dec 2011 | B2 |
8091727 | Domkowwski | Jan 2012 | B2 |
8118788 | Frezza | Feb 2012 | B2 |
8120484 | Chisholm | Feb 2012 | B2 |
8137324 | Bobst | Mar 2012 | B2 |
8140349 | Hanson et al. | Mar 2012 | B2 |
8252247 | Ferlic | Aug 2012 | B2 |
8257286 | Meyer et al. | Sep 2012 | B2 |
8328082 | Bochenko et al. | Dec 2012 | B1 |
8348895 | Vitello | Jan 2013 | B1 |
8353869 | Ranalletta et al. | Jan 2013 | B2 |
8413811 | Arendt | Apr 2013 | B1 |
8443999 | Reinders | May 2013 | B1 |
D684057 | Kwon | Jun 2013 | S |
8512277 | Del Vecchio | Aug 2013 | B2 |
8528757 | Bisio | Sep 2013 | B2 |
8556074 | Turner et al. | Oct 2013 | B2 |
8579116 | Pether et al. | Nov 2013 | B2 |
8591462 | Vitello | Nov 2013 | B1 |
8597255 | Emmott et al. | Dec 2013 | B2 |
8597271 | Langan et al. | Dec 2013 | B2 |
8616413 | Koyama | Dec 2013 | B2 |
D701304 | Lair et al. | Mar 2014 | S |
8672902 | Ruan et al. | Mar 2014 | B2 |
8702674 | Bochenko | Apr 2014 | B2 |
8777910 | Bauss et al. | Jul 2014 | B2 |
8777930 | Swisher et al. | Jul 2014 | B2 |
8852561 | Wagner et al. | Oct 2014 | B2 |
8864021 | Vitello | Oct 2014 | B1 |
8864707 | Vitello | Oct 2014 | B1 |
8864708 | Vitello | Oct 2014 | B1 |
8911424 | Weadock et al. | Dec 2014 | B2 |
8945082 | Geiger et al. | Feb 2015 | B2 |
8978909 | Kakutani et al. | Mar 2015 | B2 |
9016473 | Tamarindo | Apr 2015 | B2 |
9027769 | Willows et al. | May 2015 | B2 |
9082157 | Gibson | Jul 2015 | B2 |
9101534 | Bochenko | Aug 2015 | B2 |
D738495 | Strong et al. | Sep 2015 | S |
9125976 | Uber, III et al. | Sep 2015 | B2 |
D743019 | Schultz | Nov 2015 | S |
9192443 | Tennican | Nov 2015 | B2 |
9199042 | Farrar et al. | Dec 2015 | B2 |
9199749 | Vitello et al. | Dec 2015 | B1 |
9220486 | Schweiss et al. | Dec 2015 | B2 |
9220577 | Jessop et al. | Dec 2015 | B2 |
9227019 | Swift et al. | Jan 2016 | B2 |
D750228 | Strong et al. | Feb 2016 | S |
9272099 | Limaye et al. | Mar 2016 | B2 |
9311592 | Vitello et al. | Apr 2016 | B1 |
D756777 | Berge et al. | May 2016 | S |
9336669 | Bowden et al. | May 2016 | B2 |
D759486 | Ingram et al. | Jun 2016 | S |
D760384 | Niunoya et al. | Jun 2016 | S |
D760902 | Persson | Jul 2016 | S |
9402967 | Vitello | Aug 2016 | B1 |
9427715 | Palazzolo et al. | Aug 2016 | B2 |
9433768 | Tekeste et al. | Sep 2016 | B2 |
9463310 | Vitello | Oct 2016 | B1 |
D773043 | Ingram et al. | Nov 2016 | S |
D777903 | Schultz | Jan 2017 | S |
9662456 | Woehr | May 2017 | B2 |
D789529 | Davis et al. | Jun 2017 | S |
9687249 | Hanlon et al. | Jun 2017 | B2 |
9694948 | Pakhomov | Jul 2017 | B1 |
9744304 | Swift et al. | Aug 2017 | B2 |
D797928 | Davis et al. | Sep 2017 | S |
D797929 | Davis et al. | Sep 2017 | S |
9764098 | Hund et al. | Sep 2017 | B2 |
9821152 | Vitello et al. | Nov 2017 | B1 |
D806241 | Swinney et al. | Dec 2017 | S |
D807503 | Davis et al. | Jan 2018 | S |
9855191 | Vitello et al. | Jan 2018 | B1 |
D815945 | Fischer | Apr 2018 | S |
9987438 | Stillson | Jun 2018 | B2 |
D825746 | Davis et al. | Aug 2018 | S |
10039913 | Yeh et al. | Aug 2018 | B2 |
D831201 | Holtz et al. | Oct 2018 | S |
D834187 | Ryan | Nov 2018 | S |
10124122 | Zenker | Nov 2018 | B2 |
10166343 | Hunt et al. | Jan 2019 | B1 |
10166347 | Vitello | Jan 2019 | B1 |
10183129 | Vitello | Jan 2019 | B1 |
10207099 | Vitello | Feb 2019 | B1 |
D842464 | Davis et al. | Mar 2019 | S |
D847373 | Hurwit et al. | Apr 2019 | S |
10293987 | Sattig et al. | May 2019 | B2 |
10300263 | Hunt | May 2019 | B1 |
10307548 | Hunt et al. | Jun 2019 | B1 |
10315024 | Vitello et al. | Jun 2019 | B1 |
10315808 | Taylor et al. | Jun 2019 | B2 |
10376655 | Pupke et al. | Aug 2019 | B2 |
D859125 | Weagle et al. | Sep 2019 | S |
10478262 | Niese et al. | Nov 2019 | B2 |
10555872 | Thorne | Feb 2020 | B1 |
10758684 | Vitello et al. | Sep 2020 | B1 |
10773067 | Davis et al. | Sep 2020 | B2 |
10800556 | Thorne et al. | Oct 2020 | B2 |
D903865 | Banik et al. | Dec 2020 | S |
10888672 | Vitello | Jan 2021 | B1 |
10898659 | Vitello et al. | Jan 2021 | B1 |
10912898 | Vitello et al. | Feb 2021 | B1 |
10933202 | Banik | Mar 2021 | B1 |
10940087 | Thorne et al. | Mar 2021 | B2 |
10953162 | Hunt et al. | Mar 2021 | B1 |
11040149 | Banik | Jun 2021 | B1 |
11040154 | Vitello et al. | Jun 2021 | B1 |
11097071 | Hunt et al. | Aug 2021 | B1 |
11278681 | Banik et al. | Mar 2022 | B1 |
D948713 | Banik | Apr 2022 | S |
11357588 | Vitello et al. | Jun 2022 | B1 |
11413406 | Vitello et al. | Aug 2022 | B1 |
11426328 | Ollmann et al. | Aug 2022 | B1 |
11471610 | Banik et al. | Oct 2022 | B1 |
11523970 | Vitello et al. | Dec 2022 | B1 |
11541180 | Vitello et al. | Jan 2023 | B1 |
11690994 | Banik et al. | Jul 2023 | B1 |
11697527 | Hendren et al. | Jul 2023 | B1 |
11779520 | Vitello | Oct 2023 | B1 |
11793987 | Vitello et al. | Oct 2023 | B1 |
11857751 | Vitello | Jan 2024 | B1 |
11872187 | Vitello et al. | Jan 2024 | B1 |
11904149 | Vitello et al. | Feb 2024 | B1 |
11911339 | Lehel et al. | Feb 2024 | B1 |
12070591 | Vitello | Aug 2024 | B1 |
20010003150 | Imbert | Jun 2001 | A1 |
20010034506 | Hirschman et al. | Oct 2001 | A1 |
20010056258 | Evans | Dec 2001 | A1 |
20020007147 | Capes et al. | Jan 2002 | A1 |
20020023409 | Py | Feb 2002 | A1 |
20020046962 | Vallans et al. | Apr 2002 | A1 |
20020079281 | Hierzer et al. | Jun 2002 | A1 |
20020097396 | Schafer | Jul 2002 | A1 |
20020099334 | Hanson et al. | Jul 2002 | A1 |
20020101656 | Blumenthal et al. | Aug 2002 | A1 |
20020104770 | Shapeton et al. | Aug 2002 | A1 |
20020133119 | Eakins et al. | Sep 2002 | A1 |
20030055685 | Cobb et al. | Mar 2003 | A1 |
20030146617 | Franko, Sr. | Aug 2003 | A1 |
20030183547 | Heyman | Oct 2003 | A1 |
20030187403 | Balestracci | Oct 2003 | A1 |
20040008123 | Carrender et al. | Jan 2004 | A1 |
20040064095 | Vitello | Apr 2004 | A1 |
20040116858 | Heinz et al. | Jun 2004 | A1 |
20040173563 | Kim et al. | Sep 2004 | A1 |
20040186437 | Frenette et al. | Sep 2004 | A1 |
20040225258 | Balestracci | Nov 2004 | A1 |
20050146081 | MacLean et al. | Jul 2005 | A1 |
20050148941 | Farrar et al. | Jul 2005 | A1 |
20050209555 | Middleton et al. | Sep 2005 | A1 |
20060049948 | Chen et al. | Mar 2006 | A1 |
20060084925 | Ramsahoye | Apr 2006 | A1 |
20060089601 | Dionigi | Apr 2006 | A1 |
20060169611 | Prindle | Aug 2006 | A1 |
20060173415 | Cummins | Aug 2006 | A1 |
20060189933 | Alheidt et al. | Aug 2006 | A1 |
20070060898 | Shaughnessy et al. | Mar 2007 | A1 |
20070106234 | Klein | May 2007 | A1 |
20070142786 | Lampropoulos et al. | Jun 2007 | A1 |
20070191690 | Hasse et al. | Aug 2007 | A1 |
20070219503 | Loop et al. | Sep 2007 | A1 |
20070257111 | Ortenzi | Nov 2007 | A1 |
20080068178 | Meyer | Mar 2008 | A1 |
20080097310 | Buehler et al. | Apr 2008 | A1 |
20080106388 | Knight | May 2008 | A1 |
20080140020 | Shirley | Jun 2008 | A1 |
20080243088 | Evans | Oct 2008 | A1 |
20080303267 | Schnell et al. | Dec 2008 | A1 |
20080306443 | Neer | Dec 2008 | A1 |
20090084804 | Caspary et al. | Apr 2009 | A1 |
20090099552 | Levy et al. | Apr 2009 | A1 |
20090149815 | Kiel et al. | Jun 2009 | A1 |
20090166311 | Claessens | Jul 2009 | A1 |
20090212954 | Adstedt et al. | Aug 2009 | A1 |
20090326481 | Swisher et al. | Dec 2009 | A1 |
20100050351 | Colantonio et al. | Mar 2010 | A1 |
20100051491 | Lampropoulos et al. | Mar 2010 | A1 |
20100084403 | Popish et al. | Apr 2010 | A1 |
20100089862 | Schmitt | Apr 2010 | A1 |
20100126894 | Koukol et al. | May 2010 | A1 |
20100179822 | Reppas | Jul 2010 | A1 |
20100211016 | Palmer-Felgate | Aug 2010 | A1 |
20100228226 | Nielsen | Sep 2010 | A1 |
20100252564 | Martinez et al. | Oct 2010 | A1 |
20100283238 | Deighan et al. | Nov 2010 | A1 |
20110044850 | Solomon et al. | Feb 2011 | A1 |
20110046550 | Schiller et al. | Feb 2011 | A1 |
20110046603 | Felsovalyi et al. | Feb 2011 | A1 |
20120064515 | Knapp et al. | Mar 2012 | A2 |
20120096957 | Ochman | Apr 2012 | A1 |
20120110950 | Schraudolph | May 2012 | A1 |
20130018356 | Prince et al. | Jan 2013 | A1 |
20130018536 | Prince et al. | Jan 2013 | A1 |
20130056130 | Alpert et al. | Mar 2013 | A1 |
20130088354 | Thomas | Apr 2013 | A1 |
20130237949 | Miller | Sep 2013 | A1 |
20130269592 | Heacock et al. | Oct 2013 | A1 |
20140000781 | Franko, Jr. | Jan 2014 | A1 |
20140034536 | Reinhardt et al. | Feb 2014 | A1 |
20140069202 | Fisk | Mar 2014 | A1 |
20140069829 | Evans | Mar 2014 | A1 |
20140076840 | Graux et al. | Mar 2014 | A1 |
20140135738 | Panian | May 2014 | A1 |
20140155868 | Nelson et al. | Jun 2014 | A1 |
20140163465 | Bartlett, II et al. | Jun 2014 | A1 |
20140257843 | Adler et al. | Sep 2014 | A1 |
20140326727 | Jouin et al. | Nov 2014 | A1 |
20140353196 | Key | Dec 2014 | A1 |
20150013811 | Carrel et al. | Jan 2015 | A1 |
20150048045 | Miceli et al. | Feb 2015 | A1 |
20150112296 | Ishiwata et al. | Apr 2015 | A1 |
20150136632 | Moir et al. | May 2015 | A1 |
20150182686 | Okihara | Jul 2015 | A1 |
20150191633 | De Boer et al. | Jul 2015 | A1 |
20150246185 | Heinz | Sep 2015 | A1 |
20150251820 | Glaser | Sep 2015 | A1 |
20150302232 | Strassburger et al. | Oct 2015 | A1 |
20150305982 | Bochenko | Oct 2015 | A1 |
20150310771 | Atkinson et al. | Oct 2015 | A1 |
20160067144 | Chang | Mar 2016 | A1 |
20160067422 | Davis et al. | Mar 2016 | A1 |
20160090456 | Ishimaru et al. | Mar 2016 | A1 |
20160136352 | Smith et al. | May 2016 | A1 |
20160144119 | Limaye et al. | May 2016 | A1 |
20160158110 | Swisher et al. | Jun 2016 | A1 |
20160158449 | Limaye et al. | Jun 2016 | A1 |
20160176550 | Viitello et al. | Jun 2016 | A1 |
20160194121 | Ogawa et al. | Jul 2016 | A1 |
20160250420 | Maritan et al. | Sep 2016 | A1 |
20160279032 | Davis | Sep 2016 | A1 |
20160328586 | Bowden et al. | Nov 2016 | A1 |
20160361235 | Swisher | Dec 2016 | A1 |
20160367439 | Davis et al. | Dec 2016 | A1 |
20170007771 | Duinat et al. | Jan 2017 | A1 |
20170014310 | Hyun et al. | Jan 2017 | A1 |
20170124289 | Hasan et al. | May 2017 | A1 |
20170173321 | Davis et al. | Jun 2017 | A1 |
20170203086 | Davis | Jul 2017 | A1 |
20170225843 | Glaser et al. | Aug 2017 | A1 |
20170239141 | Davis et al. | Aug 2017 | A1 |
20170297781 | Kawamura | Oct 2017 | A1 |
20170319438 | Davis et al. | Nov 2017 | A1 |
20170349335 | Sattig et al. | Dec 2017 | A1 |
20170354792 | Ward | Dec 2017 | A1 |
20180001540 | Byun | Jan 2018 | A1 |
20180014998 | Yuki et al. | Jan 2018 | A1 |
20180064604 | Drmanovic | Mar 2018 | A1 |
20180078684 | Peng et al. | Mar 2018 | A1 |
20180089593 | Patel et al. | Mar 2018 | A1 |
20180098915 | Rajagopal et al. | Apr 2018 | A1 |
20180147115 | Nishioka et al. | May 2018 | A1 |
20180312305 | Rognard | Nov 2018 | A1 |
20190308006 | Erekovcanski et al. | Oct 2019 | A1 |
20190388626 | Okihara | Dec 2019 | A1 |
20220008645 | Ukai et al. | Jan 2022 | A1 |
20220339067 | Christine et al. | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
202008018507 | Feb 2015 | DE |
0148116 | Jul 1985 | EP |
269920 | Jun 1988 | EP |
486367 | Jun 1938 | GB |
08002544 | Jan 1996 | JP |
101159987 | Jun 2012 | KR |
WO2008000279 | Jan 2008 | WO |
WO2017086607 | May 2015 | WO |
Entry |
---|
Arai Tsugio, Pilfering Proof Cap, Jan. 9, 1996. |
Number | Date | Country | |
---|---|---|---|
63339925 | May 2022 | US | |
63252016 | Oct 2021 | US |